1. Protein Engineering Market - Market Overview
2. Executive Summary 
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Protein Engineering Market- Market Forces
4.1. Drivers
4.1.1. Development the arena of proteomics and nanotechnology
4.1.2. Growing adoption of protein-based drugs over non-protein-based drugs
4.2. Restraints
4.2.1. Higher cost of tools and instruments used in protein engineering and its maintenance
4.3. Opportunities
4.3.1. Emerging economies
4.4. Challenges
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Protein Engineering Market- Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Protein Engineering Market, By Technology
6.1. Rational Protein Design
6.2. Irrational Protein Design
7. Protein Engineering Market, By Product Type
7.1. Instruments 
7.2. Reagents 
7.3. Services & Software
8. Protein Engineering Market, By Protein Type
8.1. Monoclonal Antibodies 
8.2. Insulin 
8.3. Erythropoietin 
8.4. Interferon 
8.5. Colony Stimulating Factor 
8.6. Growth Hormones 
8.7. Coagulation Factor 
8.8. Vaccines
9. Protein Engineering Market, By End-User
9.1. Academic Research Institutes 
9.2. Pharmaceutical & Biotechnology Companies 
9.3. Contract Research Organizations
10. Protein Engineering Market, By Geography
10.1. Europe
10.1.1. Germany
10.1.2. France
10.1.3. Italy
10.1.4. Spain
10.1.5. Russia
10.1.6. U.K.
10.1.7. Rest of Europe
10.2. Asia Pacific
10.2.1. China
10.2.2. India
10.2.3. Japan
10.2.4. South Korea
10.2.5. Rest of Asia-Pacific
10.3. North America 
10.3.1. U.S.
10.3.2. Canada
10.3.3. Mexico
10.4. Rest of the World (RoW)
10.4.1. Brazil
10.4.2. Rest of RoW
11. Protein Engineering - Market Entropy
11.1. Expansion
11.2. Technological Developments
11.3. Merger & Acquisitions, and Joint Ventures
11.4. Supply- Contract
12. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
12.1. Bio-Rad Laboratories, Inc
12.2. Eli Lilly and Company
12.3. Merck and Co., Inc.
12.4. Genentech Inc.
12.5. Johnson & Johnson
12.6. Novartis AG
12.7. GlaxoSmithKline Inc.
12.8. PerkinElmer, Inc.
12.9. General Electric Company
12.10. Waters Corporation
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
13.1. Abbreviations
13.2. Sources
13.3. Research Methodology
13.4. Bibliography
13.5. Compilation of Expert Insights
13.6. Disclaimer